However, administering DHODHi with nucleoside uptake inhibitors to also block the salvage pathway, markedly enhanced the killing effect of DHODH inhibition suggesting that this combination may be a viable approach for retinoblastoma treatment or to sensitize retinoblastoma to current treatments with alkylating agents such as melphalan. This evidence concerns the gene DHODH and retinoblastoma.